These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7794561)

  • 21. Incidence of the mucopolysaccharidoses in Northern Ireland.
    Nelson J
    Hum Genet; 1997 Dec; 101(3):355-8. PubMed ID: 9439667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of mucopolysaccharidoses in Tunisia.
    Ben Turkia H; Tebib N; Azzouz H; Abdelmoula MS; Ben Chehida A; Chemli J; Monastiri K; Chaabouni M; Sanhagi H; Zouari B; Kaabachi N; Ben Dridi MF
    Tunis Med; 2009 Nov; 87(11):782-5. PubMed ID: 20209839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electron microscopy of chorionic villus samples for prenatal diagnosis of lysosomal storage disorders.
    Fowler DJ; Anderson G; Vellodi A; Malone M; Sebire NJ
    Ultrastruct Pathol; 2007; 31(1):15-21. PubMed ID: 17455094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometry in the study of lysosomal storage disorders.
    Meikle PJ; Fuller M; Hopwood JJ
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):769-77. PubMed ID: 14528914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue.
    Hamano K; Hayashi M; Shioda K; Fukatsu R; Mizutani S
    Acta Neuropathol; 2008 May; 115(5):547-59. PubMed ID: 18060551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sanfilippo disease in Greece.
    Beratis NG; Sklower SL; Wilbur L; Matalon R
    Clin Genet; 1986 Feb; 29(2):129-32. PubMed ID: 3082543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Storage disorders presenting like mucopolysaccharidosis.
    Sanklecha MU; Kher A; Naik GG; Bharucha BA; Mahajan P
    Indian J Pediatr; 1994; 61(4):367-72. PubMed ID: 8002065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phenotypes in heteroglycanoses and sphingolipidoses (author's transl)].
    Gehler J
    Monatsschr Kinderheilkd; 1981 Nov; 129(11):610-20. PubMed ID: 6798422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy.
    Meikle PJ; Ranieri E; Simonsen H; Rozaklis T; Ramsay SL; Whitfield PD; Fuller M; Christensen E; Skovby F; Hopwood JJ
    Pediatrics; 2004 Oct; 114(4):909-16. PubMed ID: 15466084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postnatal and prenatal diagnosis of lysosomal storage diseases in the former Soviet Union.
    Krasnopolskaya XD; Mirenburg TV; Akhunov VS; Voskoboeva EY
    Wien Klin Wochenschr; 1997 Feb; 109(3):74-80. PubMed ID: 9060146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and molecular analysis of mucopolysaccharidoses in Turkey.
    Emre S; Terzioğlu M; Coşkun T; Tokath A; Ozalp I; Müller V; Hopwood J
    Turk J Pediatr; 2002; 44(1):13-7. PubMed ID: 11858372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004.
    Lin HY; Lin SP; Chuang CK; Niu DM; Chen MR; Tsai FJ; Chao MC; Chiu PC; Lin SJ; Tsai LP; Hwu WL; Lin JL
    Am J Med Genet A; 2009 May; 149A(5):960-4. PubMed ID: 19396827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and laboratorial study of 19 cases of mucopolysaccharidoses.
    Albano LM; Sugayama SS; Bertola DR; Andrade CE; Utagawa CY; Puppi F; Nader HB; Toma L; Coelho J; Leistner S; Burin M; Giugliani R; Chong AK
    Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(6):213-8. PubMed ID: 11313661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic mucopolysaccharidoses, mannosidosis, sialidosis, galactosialidosis, and I-cell disease. Ultrastructural analysis of cultured fibroblasts.
    Takahashi K; Naito M; Suzuki Y
    Acta Pathol Jpn; 1987 Mar; 37(3):385-400. PubMed ID: 3113172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities.
    Hoffmann B; Mayatepek E
    Neuropediatrics; 2005 Oct; 36(5):285-9. PubMed ID: 16217702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of the mucopolysaccharidoses in Western Australia.
    Nelson J; Crowhurst J; Carey B; Greed L
    Am J Med Genet A; 2003 Dec; 123A(3):310-3. PubMed ID: 14608657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and biochemical pathophysiology of ataxia in the sphingolipidoses.
    Philippart M
    Adv Neurol; 1978; 21():131-49. PubMed ID: 104554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA).
    Hemsley KM; Hopwood JJ
    Behav Brain Res; 2005 Mar; 158(2):191-9. PubMed ID: 15698885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interest of ultrastructural study of skin and muscle biopsies in inborn storage diseases. A report of 18 cases (author's transl)].
    Bioulac P; Coquet M; Fontan D; Micheau M; Beylot C; Vital C
    Ann Dermatol Venereol; 1980 Mar; 107(3):137-48. PubMed ID: 6266327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?
    Węgrzyn G; Jakóbkiewicz-Banecka J; Narajczyk M; Wiśniewski A; Piotrowska E; Gabig-Cimińska M; Kloska A; Słomińska-Wojewódzka M; Korzon-Burakowska A; Węgrzyn A
    Med Hypotheses; 2010 Dec; 75(6):605-9. PubMed ID: 20732748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.